REPORT ID 3577

Global Peripheral Arterial Disease (PAD) Drugs Market Research Report 2017

Publish Date
14-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the global Peripheral Arterial Disease (PAD) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Peripheral Arterial Disease (PAD) Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Peripheral Arterial Disease (PAD) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    AstraZeneca Plc. (UK)
    Bayer HealthCare Pharmaceuticals (Germany)
    Bristol-Myers Squibb Company (US)
    Merck & Co., Inc. (US)
    Proteon Therapeutics, Inc. (US)
    Sanofi S.A. (France)
    Symic Bio, Inc. (US)
    TheraVasc Inc. (US)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Clopidogrel (Plavix)
    Prasugrel (Effient)
    Ticagrelor (Brilinta)
    Vorapaxar (Zontivity)
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospitals
    Clinics
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Peripheral Arterial Disease (PAD) Drugs Market Research Report 2017
1 Peripheral Arterial Disease (PAD) Drugs Market Overview
    1.1 Product Overview and Scope of Peripheral Arterial Disease (PAD) Drugs
    1.2 Peripheral Arterial Disease (PAD) Drugs Segment by Type (Product Category)
        1.2.1 Global Peripheral Arterial Disease (PAD) Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Peripheral Arterial Disease (PAD) Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Clopidogrel (Plavix)
        1.2.4 Prasugrel (Effient)
        1.2.5 Ticagrelor (Brilinta)
        1.2.6 Vorapaxar (Zontivity)
        1.2.7 Others
    1.3 Global Peripheral Arterial Disease (PAD) Drugs Segment by Application
        1.3.1 Peripheral Arterial Disease (PAD) Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Peripheral Arterial Disease (PAD) Drugs Market by Region (2012-2022)
        1.4.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Peripheral Arterial Disease (PAD) Drugs (2012-2022)
        1.5.1 Global Peripheral Arterial Disease (PAD) Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Peripheral Arterial Disease (PAD) Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Peripheral Arterial Disease (PAD) Drugs Market Competition by Manufacturers
    2.1 Global Peripheral Arterial Disease (PAD) Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Peripheral Arterial Disease (PAD) Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Peripheral Arterial Disease (PAD) Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Peripheral Arterial Disease (PAD) Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Peripheral Arterial Disease (PAD) Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Peripheral Arterial Disease (PAD) Drugs Market Competitive Situation and Trends
        2.5.1 Peripheral Arterial Disease (PAD) Drugs Market Concentration Rate
        2.5.2 Peripheral Arterial Disease (PAD) Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Peripheral Arterial Disease (PAD) Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Peripheral Arterial Disease (PAD) Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Peripheral Arterial Disease (PAD) Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Peripheral Arterial Disease (PAD) Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Peripheral Arterial Disease (PAD) Drugs Consumption by Region (2012-2017)
    4.2 North America Peripheral Arterial Disease (PAD) Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Peripheral Arterial Disease (PAD) Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Peripheral Arterial Disease (PAD) Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Peripheral Arterial Disease (PAD) Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Peripheral Arterial Disease (PAD) Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Peripheral Arterial Disease (PAD) Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Peripheral Arterial Disease (PAD) Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Peripheral Arterial Disease (PAD) Drugs Price by Type (2012-2017)
    5.4 Global Peripheral Arterial Disease (PAD) Drugs Production Growth by Type (2012-2017)

6 Global Peripheral Arterial Disease (PAD) Drugs Market Analysis by Application
    6.1 Global Peripheral Arterial Disease (PAD) Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Peripheral Arterial Disease (PAD) Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Peripheral Arterial Disease (PAD) Drugs Manufacturers Profiles/Analysis
    7.1 AstraZeneca Plc. (UK)
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Peripheral Arterial Disease (PAD) Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bayer HealthCare Pharmaceuticals (Germany)
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Peripheral Arterial Disease (PAD) Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Bristol-Myers Squibb Company (US)
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Peripheral Arterial Disease (PAD) Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Merck & Co., Inc. (US)
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Peripheral Arterial Disease (PAD) Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Proteon Therapeutics, Inc. (US)
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Peripheral Arterial Disease (PAD) Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Sanofi S.A. (France)
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Peripheral Arterial Disease (PAD) Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Symic Bio, Inc. (US)
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Peripheral Arterial Disease (PAD) Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 TheraVasc Inc. (US)
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Peripheral Arterial Disease (PAD) Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview

8 Peripheral Arterial Disease (PAD) Drugs Manufacturing Cost Analysis
    8.1 Peripheral Arterial Disease (PAD) Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Peripheral Arterial Disease (PAD) Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Peripheral Arterial Disease (PAD) Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Peripheral Arterial Disease (PAD) Drugs Market Forecast (2017-2022)
    12.1 Global Peripheral Arterial Disease (PAD) Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Peripheral Arterial Disease (PAD) Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Peripheral Arterial Disease (PAD) Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Peripheral Arterial Disease (PAD) Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Peripheral Arterial Disease (PAD) Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Peripheral Arterial Disease (PAD) Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer